BioCentury | Jun 25, 2019
Financial News

June 25 Financial Quick Takes: Tasly unit planning Hong Kong IPO; plus Vesalius, Mirati and more

...testing for cancer, metabolic, gastrointestinal, cardiovascular and autoimmune diseases. Vesalius closes fund at €120 million Vesalius Biocapital Partners...
...1Q20. Hongjiang Li and Elizabeth S. Eaton, Staff Writers ArQule Inc. Krystal Biotech Inc. Mirati Therapeutics Inc. Tasly Pharmaceutical Co. Ltd. Vesalius Biocapital Partners BioEclipse...
BioCentury | Nov 10, 2017
Finance

Making introductions

...life sciences investors Alain Parthoens and Goro Takeda. Parthoens is co-founder and managing partner at Vesalius Biocapital Partners...
BioCentury | May 19, 2017
Finance

Larger and later

...only ex-European investment to date. The fund's first investment is expected next half. Virginia Li, Staff Writer Vesalius Biocapital Partners...
BioCentury | May 19, 2017
Financial News

Vesalius raises EUR 67M towards third fund

...On May 18, life sciences investor Vesalius Biocapital Partners S.a.r.l (Luxembourg, Luxembourg) raised €67 million ($73.3 million) in...
...planned €150 million ($164.1 million) life sciences fund. The final close is expected in 2018. Vesalius Biocapital Partners...
BioCentury | May 18, 2017
Financial News

Vesalius raises €67M towards third fund

...health. It is targeting 10-15 investments, and expects to make the first deal next half. Virginia Li Vesalius Biocapital Partners...
BioCentury | Apr 3, 2017
Company News

Ogeda takeout gives Astellas hot flashes candidate

...in its €18 million ($19.8 million) series B round included SFPI-FPIM, Fund+, Capricorn Health-Tech Fund, Vesalius Biocapital Partners...
BioCentury | Oct 12, 2015
Financial News

Euroscreen completes venture financing

...Proteomics Date completed: 2015-10-02 Type: Venture financing Raised: EUR16 million ($18 million) Investors: SFPI-FPIM; Fund+; Vesalius Biocapital Partners...
BioCentury | Oct 5, 2015
Financial News

Apitope completes venture financing

...2015-09-29 Type: Venture financing Raised: EUR12 million ($13.4 million) Investors: Wales Life Sciences Investment Fund; Vesalius Biocapital Partners...
BioCentury | Apr 20, 2015
Financial News

Omeicos Therapeutics completes venture financing

...Germany Business: Cardiovascular Date completed: 2015-04-15 Type: Venture financing Raised: EUR6.2 million ($6.5 million) Investors: Vesalius Biocapital Partners...
BioCentury | Jan 12, 2015
Financial News

Genkyotex completes venture financing

...$19.9 million) Investors: NeoMed; VI Partners; Biomed Invest; Edmond de Rothschild Investment Partners; Eclosion S.A.; Vesalius Biocapital Partners WIR...
Items per page:
1 - 10 of 30
BioCentury | Jun 25, 2019
Financial News

June 25 Financial Quick Takes: Tasly unit planning Hong Kong IPO; plus Vesalius, Mirati and more

...testing for cancer, metabolic, gastrointestinal, cardiovascular and autoimmune diseases. Vesalius closes fund at €120 million Vesalius Biocapital Partners...
...1Q20. Hongjiang Li and Elizabeth S. Eaton, Staff Writers ArQule Inc. Krystal Biotech Inc. Mirati Therapeutics Inc. Tasly Pharmaceutical Co. Ltd. Vesalius Biocapital Partners BioEclipse...
BioCentury | Nov 10, 2017
Finance

Making introductions

...life sciences investors Alain Parthoens and Goro Takeda. Parthoens is co-founder and managing partner at Vesalius Biocapital Partners...
BioCentury | May 19, 2017
Finance

Larger and later

...only ex-European investment to date. The fund's first investment is expected next half. Virginia Li, Staff Writer Vesalius Biocapital Partners...
BioCentury | May 19, 2017
Financial News

Vesalius raises EUR 67M towards third fund

...On May 18, life sciences investor Vesalius Biocapital Partners S.a.r.l (Luxembourg, Luxembourg) raised €67 million ($73.3 million) in...
...planned €150 million ($164.1 million) life sciences fund. The final close is expected in 2018. Vesalius Biocapital Partners...
BioCentury | May 18, 2017
Financial News

Vesalius raises €67M towards third fund

...health. It is targeting 10-15 investments, and expects to make the first deal next half. Virginia Li Vesalius Biocapital Partners...
BioCentury | Apr 3, 2017
Company News

Ogeda takeout gives Astellas hot flashes candidate

...in its €18 million ($19.8 million) series B round included SFPI-FPIM, Fund+, Capricorn Health-Tech Fund, Vesalius Biocapital Partners...
BioCentury | Oct 12, 2015
Financial News

Euroscreen completes venture financing

...Proteomics Date completed: 2015-10-02 Type: Venture financing Raised: EUR16 million ($18 million) Investors: SFPI-FPIM; Fund+; Vesalius Biocapital Partners...
BioCentury | Oct 5, 2015
Financial News

Apitope completes venture financing

...2015-09-29 Type: Venture financing Raised: EUR12 million ($13.4 million) Investors: Wales Life Sciences Investment Fund; Vesalius Biocapital Partners...
BioCentury | Apr 20, 2015
Financial News

Omeicos Therapeutics completes venture financing

...Germany Business: Cardiovascular Date completed: 2015-04-15 Type: Venture financing Raised: EUR6.2 million ($6.5 million) Investors: Vesalius Biocapital Partners...
BioCentury | Jan 12, 2015
Financial News

Genkyotex completes venture financing

...$19.9 million) Investors: NeoMed; VI Partners; Biomed Invest; Edmond de Rothschild Investment Partners; Eclosion S.A.; Vesalius Biocapital Partners WIR...
Items per page:
1 - 10 of 30